REGENERON PHARMACEUTICALS, INC. Logo

REGENERON PHARMACEUTICALS, INC.

A biotech firm inventing, developing, and commercializing medicines for serious diseases.

REGN | US

Overview

Corporate Details

ISIN(s):
US75886F1075
LEI:
Country:
United States of America
Address:
777 OLD SAW MILL RIVER ROAD, 10591 TARRYTOWN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents, develops, manufactures, and commercializes medicines for people with serious diseases. Founded in 1988, the company leverages its scientific and technological capabilities to produce a portfolio of treatments and a pipeline of product candidates. Its research and development efforts span multiple therapeutic areas, including ophthalmology, oncology, cardiovascular and metabolic diseases, and inflammatory conditions. Regeneron focuses on turning cutting-edge science into transformative medicines, with active programs in areas such as genetic medicines (including CRISPR), cancer-fighting immunotherapies, and treatments for obesity.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all REGENERON PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for REGENERON PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for REGENERON PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops and produces IVD kits and biological pharmaceuticals for the healthcare sector.
Türkiye
RTALB
RYTHM, Inc. Logo
Manages cannabis & hemp brands offering full-spectrum flower, vapes, and beverages.
United States of America
RYM
SAB Biotherapeutics, Inc. Logo
Develops human polyclonal antibodies for autoimmune disorders and infectious diseases.
United States of America
SABS
Sagimet Biosciences Inc. Logo
Clinical-stage biopharma developing FASN inhibitors for MASH, acne, and cancer.
United States of America
SGMT
SAMIL PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs for eye & liver diseases, with a broad portfolio & CDMO services.
South Korea
000520
SAMJIN PHARMACEUTICAL CO.,LTD Logo
Researches & develops drugs for cardiovascular, respiratory, and gastrointestinal disorders.
South Korea
005500
SAMSUNG BIOLOGICS CO.,LTD. Logo
A CDMO providing end-to-end development and manufacturing services for the biopharma industry.
South Korea
207940
Sana Biotechnology, Inc. Logo
Engineering cells as medicine to repair genes and treat cancer, diabetes, and autoimmune disorders.
United States of America
SANA
SanBio Company Limited Logo
Developing regenerative cell therapies for severe neurological disorders like brain injury and stroke.
Japan
4592
SANGAMO THERAPEUTICS, INC Logo
Developing genomic cures for severe genetic diseases using proprietary zinc finger technology.
United States of America
SGMO

Talk to a Data Expert

Have a question? We'll get back to you promptly.